DNA methylation in circulating leukocytes is a novel biomarker in multiple myeloma. Bone Marrow Transplant 2023 Mar;58(3):334-336
Date
12/03/2022Pubmed ID
36460820DOI
10.1038/s41409-022-01887-0Scopus ID
2-s2.0-85143207078 (requires institutional sign-in at Scopus site)Author List
D'Souza A, Brazauskas R, Teng BQ, Yun G, Uttley H, Dong J, Dwinell MB, Pasquini MC, Giralt S, Landau H, Stadtmauer E, Krishnan A, Janz SAuthors
Ruta Brazauskas PhD Associate Professor in the Institute for Health and Equity department at Medical College of WisconsinAnita D'Souza MD Associate Professor in the Medicine department at Medical College of Wisconsin
Jing Dong PhD Assistant Professor in the Medicine department at Medical College of Wisconsin
Michael B. Dwinell PhD Director, Professor in the Microbiology and Immunology department at Medical College of Wisconsin
Siegfried Janz MD Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
Bi Qing Teng Biostatistician II in the Institute for Health and Equity department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
BiomarkersDNA Methylation
Humans
Leukocytes
Multiple Myeloma
